Inhibikase Therapeutics I... (IKT)
NASDAQ: IKT
· Real-Time Price · USD
1.77
-0.07 (-3.80%)
At close: May 23, 2025, 3:59 PM
1.77
0.00%
After-hours: May 23, 2025, 04:04 PM EDT
-3.80% (1D)
| Bid | 1.75 |
| Market Cap | 131.58M |
| Revenue (ttm) | 26.27K |
| Net Income (ttm) | -36.55M |
| EPS (ttm) | -0.58 |
| PE Ratio (ttm) | -3.05 |
| Forward PE | -4.02 |
| Analyst | Hold |
| Ask | 2.27 |
| Volume | 136,960 |
| Avg. Volume (20D) | 134,007 |
| Open | 1.82 |
| Previous Close | 1.84 |
| Day's Range | 1.76 - 1.92 |
| 52-Week Range | 1.12 - 4.20 |
| Beta | 1.01 |
Analyst Forecast
According to 0 analyst ratings, the average rating for IKT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
-13.14%
Inhibikase Therapeutics shares are trading lower. ...
Unlock content with
Pro Subscription
6 months ago
+3.6%
Inhibikase Therapeutics shares are trading higher after Jefferies initiated coverage on the stock with a Buy rating and announced an $8 price target.
